Biomedical Approach of Nanotechnology and Biological Risks: A Mini-Review

Abstract

Nanotechnology has played a prominent role in biomedical engineering, offering innovative approaches to numerous treatments. Notable advances have been observed in the development of medical devices, contributing to the advancement of modern medicine. This article briefly discusses key applications of nanotechnology in tissue engineering, controlled drug release systems, biosensors and monitoring, and imaging and diagnosis. The particular emphasis on this theme will result in a better understanding, selection, and technical approach to nanomaterials for biomedical purposes, including biological risks, security, and biocompatibility criteria.

What is the role of microbial biotechnology and genetic engineering in medicine?

“…The introduction of bioplastics to the market has opened a new perspective in the field of medicine. Due to their bioresorbability, these bioplastics can pass through biological barriers and concentrate in specific tissues (Silva et al, 2023 ). Among all existing bioplastics, only polyhydroxyalkanoates (PHAs) are fully synthesized by prokaryotic microorganisms (Bordel et al, 2021 ).…”

“…Nonetheless, PHAs are driving the growth of the biodegradable bioplastics market, and the production capacity is expected to triple in the next 5 years. Therefore, it is anticipated that similar to PLA and PLGA, natural PHA biopolymers will soon find various applications in the biomedical field, offering innovative approaches to numerous treatments and contributing to the advancement of modern medicine (Bhatia et al, 2021 ; Silva et al, 2023 ).…”

Special Issue “Bio-Nano Interactions 2.0”

“…Hence, understanding how the biological factors can be addressed or exploited can guide the design of better and more tailored nanomaterials to improve their functioning as nanomedicines, with the aim of working with and not against biology. Exerting a control at the nanoscale is key, which has already promoted progresses for the development of nanotechnologies able to self-organize for tissue regeneration [9]. In this context, the use of engineered biomolecules, such as nucleic acids, enabled us to develop self-assembled hybrid nano-objects with machine-like properties, using simple Watson-Crick base-pairing rules [10,11].…”